About
Mesoblast develops allogeneic cellular medicines targeting inflammatory diseases and other serious medical conditions using regenerative medicine technologies.
Explore Mesoblast's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.